COMPANIES COVERED
F. Hoffmann-La RocheDownload FREE Report Sample
Download Free sampleNeuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.
Neuroprotection Market contains market size and forecasts of Neuroprotection in Global, including the following market information:
Global Neuroprotection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neuroprotection market was valued at 24070 million in 2021 and is projected to reach US$ 32340 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Free Anti-Inflammatory Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuroprotection include F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuroprotection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroprotection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuroprotection Market Segment Percentages, by Type, 2021 (%)
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Others
Global Neuroprotection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuroprotection Market Segment Percentages, by Application, 2021 (%)
Prevention
Treatment
Global Neuroprotection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuroprotection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuroprotection revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neuroprotection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy's Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
Biogen
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
